I Gardner

Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol.

J. Caldwell, J. G. Kenna, I. Gardner, 1996, Chemical research in toxicology.

Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man.

I. Gardner, I Gardner, T. Jenkins, 2008, Xenobiotica; the fate of foreign compounds in biological systems.

Incorporating Target Shedding Into a Minimal PBPK–TMDD Model for Monoclonal Antibodies

M Jamei, M. Jamei, I. Gardner, 2014, CPT: pharmacometrics & systems pharmacology.

Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.

P. Beaune, I. de Waziers, J. Caldwell, 1997, Carcinogenesis.

An Introduction to Drug Disposition: The Basic Principles of Absorption, Distribution, Metabolism, and Excretion

J. Caldwell, I. Gardner, I Gardner, 1995, Toxicologic pathology.

Immunochemical identification of hepatic protein adducts derived from estragole.

I Gardner, J G Kenna, J Caldwell, 1998, Chemical research in toxicology.

Development of a Multicompartment Permeability-Limited Lung PBPK Model and Its Application in Predicting Pulmonary Pharmacokinetics of Antituberculosis Drugs

M Jamei, L Almond, M. Jamei, 2015, CPT: pharmacometrics & systems pharmacology.

Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae

A. Fleming, W. Alderton, I. Gardner, 2010, Xenobiotica; the fate of foreign compounds in biological systems.

VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays.

M Jamei, M. Jamei, C. Fisher, 2019, Toxicology in vitro : an international journal published in association with BIBRA.